APA

Tay R. Y., Fernández-Gutiérrez F., Foy V., Burns K., Pierce J., Morris K., Priest L., Tugwood J., Ashcroft L., Lindsay C. R., Faivre-Finn C., Dive C. & Blackhall F. (20200623). Prognostic value of circulating tumour cells in limited-stage small-cell lung cancer: analysis of the concurrent once-daily versus twice-daily radiotherapy (CONVERT) randomised controlled trial. : Annals of oncology : official journal of the European Society for Medical Oncology.

Chicago

Tay R Y, Fernández-Gutiérrez F, Foy V, Burns K, Pierce J, Morris K, Priest L, Tugwood J, Ashcroft L, Lindsay C R, Faivre-Finn C, Dive C and Blackhall F. 20200623. Prognostic value of circulating tumour cells in limited-stage small-cell lung cancer: analysis of the concurrent once-daily versus twice-daily radiotherapy (CONVERT) randomised controlled trial. : Annals of oncology : official journal of the European Society for Medical Oncology.

Harvard

Tay R. Y., Fernández-Gutiérrez F., Foy V., Burns K., Pierce J., Morris K., Priest L., Tugwood J., Ashcroft L., Lindsay C. R., Faivre-Finn C., Dive C. and Blackhall F. (20200623). Prognostic value of circulating tumour cells in limited-stage small-cell lung cancer: analysis of the concurrent once-daily versus twice-daily radiotherapy (CONVERT) randomised controlled trial. : Annals of oncology : official journal of the European Society for Medical Oncology.

MLA

Tay R Y, Fernández-Gutiérrez F, Foy V, Burns K, Pierce J, Morris K, Priest L, Tugwood J, Ashcroft L, Lindsay C R, Faivre-Finn C, Dive C and Blackhall F. Prognostic value of circulating tumour cells in limited-stage small-cell lung cancer: analysis of the concurrent once-daily versus twice-daily radiotherapy (CONVERT) randomised controlled trial. : Annals of oncology : official journal of the European Society for Medical Oncology. 20200623.